Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Oncology biomarker clinical trial CAGR globally 2000-2018, by cancer type

This statistic depicts the compound annual growth rate (CAGR) of oncology biomarker clinical trials started worldwide between 2000 and 2018, by cancer type. During these years, brain/glioma/CNS cancer clinical trials had the highest CAGR of 25.1 percent, followed closely by lung cancer clinical trials with a CAGR of 24.9 percent.

CAGR of oncology biomarker clinical trials worldwide from 2000 to 2018, by cancer type*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

November 2019

Region

Worldwide

Survey time period

2000 to 2018

Supplementary notes

* Trials looking at two or more indications are repeat counted for each indication.
** Potential pan-tumor biomarker trials were determined based on a proxy of trial activity that could potentially lead to a pan-tumor label and included oncology biomarker clinical trials in Phase 2,3 or 4 with >five specified tumors per trial or

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Cancer in Denmark "

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.